Cargando…

New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws

Detalles Bibliográficos
Autores principales: Bennardo, Francesco, Buffone, Caterina, Giudice, Amerigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270501/
https://www.ncbi.nlm.nih.gov/pubmed/32209313
http://dx.doi.org/10.1016/j.oraloncology.2020.104659
_version_ 1783541909473460224
author Bennardo, Francesco
Buffone, Caterina
Giudice, Amerigo
author_facet Bennardo, Francesco
Buffone, Caterina
Giudice, Amerigo
author_sort Bennardo, Francesco
collection PubMed
description
format Online
Article
Text
id pubmed-7270501
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72705012020-06-05 New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws Bennardo, Francesco Buffone, Caterina Giudice, Amerigo Oral Oncol Article Elsevier Ltd. 2020-07 2020-03-21 /pmc/articles/PMC7270501/ /pubmed/32209313 http://dx.doi.org/10.1016/j.oraloncology.2020.104659 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bennardo, Francesco
Buffone, Caterina
Giudice, Amerigo
New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
title New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
title_full New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
title_fullStr New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
title_full_unstemmed New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
title_short New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
title_sort new therapeutic opportunities for covid-19 patients with tocilizumab: possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270501/
https://www.ncbi.nlm.nih.gov/pubmed/32209313
http://dx.doi.org/10.1016/j.oraloncology.2020.104659
work_keys_str_mv AT bennardofrancesco newtherapeuticopportunitiesforcovid19patientswithtocilizumabpossiblecorrelationofinterleukin6receptorinhibitorswithosteonecrosisofthejaws
AT buffonecaterina newtherapeuticopportunitiesforcovid19patientswithtocilizumabpossiblecorrelationofinterleukin6receptorinhibitorswithosteonecrosisofthejaws
AT giudiceamerigo newtherapeuticopportunitiesforcovid19patientswithtocilizumabpossiblecorrelationofinterleukin6receptorinhibitorswithosteonecrosisofthejaws